Balice-Gordon Rita J. 4

What Happened
Rita J. Balice-Gordon, a director of Collegium Pharmaceutical, was granted 8,741 restricted stock units (RSUs) on 2026-05-14. The award is reported at $0.00 (no cash paid). Each RSU represents a contingent right to receive one share of Collegium common stock; the RSUs will convert into shares when they vest.

Key Details

• Transaction date: 2026-05-14; Form 4 filed 2026-05-18 (timely filing).
• Grant: 8,741 RSUs @ $0.00 (award/grant code A). Reported dollar value: $0.
• Vesting/settlement: RSUs vest on the earlier of May 14, 2027 or the 2027 Annual Meeting of Shareholders, subject to continued service. Settlement will be in shares on vesting or earlier upon the director’s election, end of service, death/disability, or a change in control (per footnote).
• Shares owned after transaction: Not disclosed in this filing.
• Exhibit noted: 24.1 — Power of Attorney.

Context
This is an equity compensation grant to a board director (not an open-market purchase or sale). RSU grants are common for aligning directors with shareholder interests but do not represent an immediate cash investment or market sentiment by the insider. Watch future Form 4 filings for settlement (when shares are actually delivered) or for any sales that follow vesting.